Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-05-11 @ 5:49 AM
Study NCT ID:
NCT02856451
Status:
COMPLETED
Last Update Posted:
2022-06-30
First Post:
2016-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Encephalitis | View |
Keywords: